,trastuzumab deruxtecan
Daiichi Sankyo,AstraZeneca
['breast', 'daiichisankyous']
so excited for the plenary today on destiny breast 04 and bringing new therapy choices to breast cancer patients on monday morning. 
Dr. Patt is a med onc, healthcare informatics specialist, and health policy expert @TexasOncology @TheUSONetwork @DellMedSchool.  All views are my own.